DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce final negotiations to target an immediate European expansion with opportune acquisitions & licensing deals. This new set of deals is designed to bring to bring new products, revenues, and executive management to the company’s growing operations. The target European company has already created its footprint distributing its products in the European Markets and around the world while meeting Cannabis Science’s standards to ensure the utmost quality control and stringent procedures.
